StartseiteMCPWorkbenchSkills
StartseiteWorkbenchBenachrichtigungenMein Bereich
llms.txt · MCP-AnleitungDatenschutz · Nutzungsbedingungen · Supportv1.8.3
  1. Startseite
  2. /Verbindung

Dinoprost

HCID 5280363
Neue Reaktion
Drucken
GrundinformationenÜberblickNamen und BezeichnerEigenschaftenSicherheit und RegulatorischesChemie und IndustrieZugehörige ReaktionenNotizen zur Verbindung
TeilstruktursucheÄhnliche Strukturen suchen

Grundinformationen

CAS
23518-25-4
Standard-SMILES
CCCCC[C@H](O)/C=C/[C@@H]1[C@@H](C/C=C\CCCC(=O)O)[C@@H](O)C[C@H]1O
InChIKey
PXGPLTODNUVGFL-YNNPMVKQSA-N
Summenformel
C20H34O5
Durchschnittliche Molmasse
354,5 g/mol
Monoisotopische Masse
354,24062418

Überblick

Prostaglandin F2alpha is a prostaglandins Falpha that is prosta-5,13-dien-1-oic acid substituted by hydroxy groups at positions 9, 11 and 15. It is a naturally occurring prostaglandin used to induce labor. It has a role as a mouse metabolite and a human metabolite. It is a monocarboxylic acid and a prostaglandins Falpha. It is a conjugate acid of a prostaglandin F2alpha(1-).

Namen und Bezeichner

Bevorzugter Name
Dinoprost
IUPAC
(Z)-7-[(1R,2R,3R,5S)-3,5-dihydroxy-2-[(E,3S)-3-hydroxyoct-1-enyl]cyclopentyl]hept-5-enoic acid
Englischer Name
(+-)-PGF2-alpha
Summenformel
C20H34O5
Molmasse
354.48

Namen und Synonyme

dinoprostprostaglandin F2alphaProstaglandin F2aPGF2alphaamoglandinEnzaprostpanacelanDinoprostaProtamodinProstaglandin F2-alphal-PGF2-alphaPGF2a
Weitere Namen anzeigen
PIGF-2(+-)-PGF2αdl-Prostaglandin F2αProsta-5,13-dien-1-oic acid, 9,11,15-trihydroxy-, (5Z,9α,11α,13E,15S)-(±)-(5Z,9α,11α,13E,15S)-(±)-9,11,15-Trihydroxyprosta-5,13-dien-1-oic acid (ACI)Prosta-5,13-dien-1-oic acid, 9,11,15-trihydroxy-, (5Z,9α,11α,13E,15S)-(+-)-5-Heptenoic acid, 7-[3,5-dihydroxy-2-(3-hydroxy-1-octenyl)cyclopentyl]-, (+-)- (8CI)
PGF-2alphaPGF2-alphaDinoprostumProsmonl-Prostaglandin F2-alphaProstarmon FProstin F2alphaProstin F2-alpha

Datenbank-Bezeichner

CAS
23518-25-4、551-11-1

Eigenschaften

Berechnete Struktureigenschaften

XLogP
2,7
Polarare Oberfläche (TPSA)
98 Ų
H-Brücken-Donoren
4
H-Brücken-Akzeptoren
5
Frei drehbare Bindungen
12
Schwere Atome
25
Formalladung
0
Komplexität
432

Experimentelle und physikochemische Eigenschaften

DrugsPharmaceuticals -> Listed in ZINC15
LipidsFatty Acyls [FA] -> Eicosanoids [FA03] -> Prostaglandins [FA0301]
LogP2.72
Color/FormNATURAL FORM, CRYSTALS
Solubility · 2 Einträge

SOL IN WATER 200 MG/ML /DINOPROST TROMETHAMINE/

FREELY SOL IN METHANOL, ABSOLUTE ETHANOL; FREELY SOL IN ETHYL ACETATE, CHLOROFORM; SLIGHTLY SOL IN WATER

Animal DrugsPharmaceuticals -> UK Veterinary Medicines Directorate List
Melting Point25-35 °C
Optical RotationSPECIFIC OPTICAL ROTATION: +23.5 DEG @ 25 °C/D (1 G IN 100 ML TETRAHYDROFURAN)
Stability/Shelf Life · 3 Einträge

STABLE FOR 2 YR IN LIGHT RESISTANT CONTAINERS @ 5-15 °C

DEGRADES IN 1 WK WHEN EXPOSED TO SUNLIGHT OR IN 3 MO @ 40 °C

Sicherheit und Regulatorisches

Sicherheitsangaben dienen nur zur Orientierung und ersetzen weder das Sicherheitsdatenblatt (SDB) des Lieferanten noch geltende Vorschriften oder eine fachliche Bewertung.

GHS-Klassifizierung

GHS Classification · 4 Einträge

Danger

H302 (100%): Harmful if swallowed [Warning Acute toxicity, oral]

P203, P260, P264, P264+P265, P270, P280, P301+P317, P305+P351+P338, P308+P316, P318, P319, P321, P330, P337+P317, P405, and P501 (click each P-code to see the statement)

Aggregated GHS information provided per 39 reports by companies from 4 notifications to the ECHA C&L Inventory. Each notification may be associated with multiple companies.

Gefahrenhinweise

Regulatory InformationDinoprost: Does not have an individual approval but may be used as a component in a product covered by a group standard. It is not approved for use as a chemical in its own right.
Hazard Classes and CategoriesAcute Tox. 4 (100%)

Toxikologische Informationen

InteractionsCONTRACTIONS IN RESPONSE TO PROSTAGLANDIN F2ALPHA IN HUMAN ISOLATED BRONCHIAL MUSCLE ARE INHIBITED BY FENAMATES, PHENYLBUTAZONE, &, LESS POTENTLY, ASPIRIN.
Human Toxicity Excerpts · 5 Einträge

INTRADERMAL INJECTION OF.../PROSTAGLANDIN F2ALPHA/ IN MAN CAUSES "WHEAL & FLARE."

SIDE EFFECTS ATTENDING USE OF PROSTAGLANDINS IN SECOND & THIRD TRIMESTER & @ TERM ARE CAUSED BY THEIR STIMULATORY ACTION ON SMOOTH MUSCLE OF ALIMENTARY TRACT, THAT IS, NAUSEA, VOMITING, & DIARRHEA. /PROSTAGLANDINS/

CERVICAL OR LOWER UTERINE LACERATION OR RUPTURE, WITH RETENTION OF PLACENTA & HEMORRHAGE, IS PERHAPS MOST IMPORTANT DANGER WITH USE...FOR 2ND-TRIMESTER ABORTION. ... FEVER, HYPOTENSION & SYNCOPE, HYPERTENSION, HEADACHE, & PAIN & ERYTHEMA @ SITE OF INJECTION OCCUR LESS FREQUENTLY. /DINOPROST TROMETHAMINE/

Chemie und Industrie

Pharmakologische Informationen

ATC Code · 2 Einträge

G - Genito urinary system and sex hormones

QG - Genito urinary system and sex hormones

Mechanism of Action · 4 Einträge

...THERE IS NO SINGLE PROSTAGLANDIN RECEPTOR. ... IT IS POSSIBLE TO DEMONSTRATE CALCIUM DEPENDENCE OF DIVERSE RESPONSES TO PROSTAGLANDINS & TO OBSERVE ALTERED CALCIUM FLUXES. ...PROSTAGLANDINS MAY EITHER STIMULATE OR INHIBIT ACCUM OF CYCLIC AMP. /PROSTAGLANDINS/

RESPONSES TO PROSTAGLANDIN F2ALPHA SHOW SPECIES VARIATION, BUT VASODILATATION HAS BEEN OBSERVED FOLLOWING INJECTION INTO HUMAN BRACHIAL ARTERY OF PGF2ALPHA... SUPERFICIAL VEINS OF HAND ARE CONTRACTED BY PFG2ALPHA...

PROMPT SUBSIDENCE OF PROGESTERONE OUTPUT & REGRESSION OF CORPUS LUTEUM FOLLOWS PARENTERAL INJECTION OF PROSTAGLANDIN F2ALPHA... THIS EFFECT INTERRUPTS EARLY PREGNANCY, WHICH IS DEPENDENT ON LUTEAL RATHER THAN PLACENTAL PROGESTERONE.

OXYTOCIN & PROSTAGLANDINS AFFECT UTERINE SMOOTH MUSCLES BY DIFFERENT MECHANISMS, & THEIR EFFECTS ARE ADDITIVE. POSSIBLE ADVANTAGES OF THEIR COMBINED USE ARE BEING EXPLORED. /PROSTAGLANDINS/

Metabolism/Metabolites...PROSTAGLANDINS ARE RAPIDLY METABOLIZED... /PROSTAGLANDINS/
MeSH Pharmacological Classification · 2 Einträge

Non-steroidal chemical compounds with abortifacient activity.

Drugs that stimulate contraction of the myometrium. They are used to induce LABOR, OBSTETRIC at term, to prevent or control postpartum or postabortion hemorrhage, and to assess fetal status in high risk pregnancies. They may also be used alone or with other drugs to induce abortions (ABORTIFACIENTS). Oxytocics used clinically include the neurohypophyseal hormone OXYTOCIN and certain prostaglandins and ergot alkaloids. (From AMA Drug Evaluations, 1994, p1157)

Absorption, Distribution and Excretion · 3 Einträge

AMONG COMPD OCCURRING IN SEMEN THAT ARE OF CURRENT RESEARCH INTEREST ARE PROSTAGLANDINS (25 MG/ML). /PROSTAGLANDINS/

APART FROM GENERALLY SLOW & SPECIES-DEPENDENT ISOMERIZATION, PGS E & F ARE RATHER STABLE IN BLOOD, BUT THEY ARE RAPIDLY DEGRADED & INACTIVATED BY TISSUE-BOUND ENZYMES; SOME 80-90% OR MORE IS DESTROYED DURING SINGLE PASSAGE THROUGH LIVER OR LUNGS. /PROSTAGLANDINS/

Zugehörige Reaktionen

39
Reaktionsaufzeichnung erstellen
Reaktionsgleichung von HRID 55777
HRID 55777als Edukt
Reaktionsgleichung von HRID 258642
HRID 258642als Edukt
Reaktionsgleichung von HRID 328230
HRID 328230als Edukt
Reaktionsgleichung von HRID 436951
HRID 436951als Edukt
Reaktionsgleichung von HRID 437096
HRID 437096als Produkt
Reaktionsgleichung von HRID 456801
HRID 456801als Edukt
Reaktionsgleichung von HRID 477215
HRID 477215als Edukt
Reaktionsgleichung von HRID 613944
HRID 613944als Edukt
ZurückSeite 1 von 5

Notizen zur Verbindung

Auf dieser SeiteGrundinformationenÜberblickNamen und BezeichnerEigenschaftenSicherheit und RegulatorischesChemie und IndustrieZugehörige ReaktionenNotizen zur Verbindung
PubChem CID
5280363
DTXSID
DTXSID9022946
ChEMBL
CHEMBL815
ChEBI
CHEBI:15553
UNII
B7IN85G1HY
EC Number
684-259-0
Nikkaji
J9.246K

STABLE IN LIGHT, AIR, & HEAT /DINOPROST TROMETHAMINE/

Collision Cross Section · 3 Einträge

191.3 Ų [M-H]- [CCS Type: DT; Buffer gas: N2; Ionization: ESI-; Calculation: Single Field; Dataset: Oxylipins]

205.7 Ų [M+Na]+ [CCS Type: DT; Method: stepped-field]

204.4 Ų [M+Na]+

Other Experimental Properties · 3 Einträge

ODORLESS, BITTER-TASTING /DINOPROST TROMETHAMINE/

MP APPROX 100 °C /DINOPROST TROMETHAMINE/

WHITE OR OFF-WHITE CRYSTALLINE POWDER /DINOPROST TROMETHAMINE/

Physikochemische Eigenschaften

Siedepunkt
407.69 °C · 407.69°C (rough estimate)
Dichte
1.0458 · 1.0458 (rough estimate)
Brechungsindex
1.612 · 1.6120 (estimate)
storage temp.
-20 °C · -20°C
pka
4.76 · 4.76±0.10(Predicted)

BRONCHOSPASM...IN...ASTHMATIC PT; GRAND MAL CONVULSIONS...OCCUR...IN PT PRONE TO EPILEPSY. VASOMOTOR REACTIONS, ARRHYTHMIAS, ATRIOVENTRICULAR CONDUCTION DISTURBANCES, HYPERVENTILATION, PARESTHESIAS & HYPERESTHESIAS, CHEST PAIN, HICCUPS, & DYSURIA HAVE BEEN OBSERVED AFTER INTRAUTERINE ADMIN... /DINOPROST TROMETHAMINE/

For more Human Toxicity Excerpts (Complete) data for PROSTAGLANDIN F2ALPHA (6 total), please visit the HSDB record page.

Non-Human Toxicity Excerpts · 1 Eintrag

IN PREGNANT RATS TREATED SC @ 50 UG, DAYS 9-11 OR 12-15 OF GESTATION, PLACENTA SHOWED EXTENSIVE AREAS OF DEGENERATION THAT ARE FOUND IN PLACENTAL INSUFFICIENCY. ALSO FETAL ADRENAL CORTEX SHOWED MORPHOLOGICAL CHANGES INDICATIVE OF INTRAUTERINE DISTRESS.

Antidote and Emergency TreatmentSINCE DINOPROST IS METABOLIZED RAPIDLY, DISCONTINUATION OF DRUG & SUPPORTIVE THERAPY ARE ADEQUATE TREATMENT...BLOOD TRANSFUSIONS MAY BE REQUIRED /FOR HEMORRHAGE DUE TO RETENTION OF PLACENTA/

Sicherheitsdaten

risk_code
20-35
hazard_code
C
safety_code
26-36/37/39-45

DEG OF BINDING OF PROSTAGLANDINS TO PLASMA PROTEINS APPEARS TO HAVE LITTLE INFLUENCE ON THEIR RATES OF METABOLISM & ELIMINATION. ... CLEARANCE RATES OF (3)H DID NOT CHANGE WHETHER PROSTAGLANDINS WERE ADMIN IN FREE FORM OR BOUND TO RAT PLASMA ALBUMIN. /PROSTAGLANDINS/

Verwendung und Herstellung

Uses · 2 Einträge

MEDICATION (VET)

MEDICATION

Methods of Manufacturing...SYNTH OF NATURAL PROSTAGLANDIN F2ALPHA: SCHNEIDER, MURRAY, J ORG CHEM 38, 397 (1973).
Formulations/Preparations...SOLN CONTAINING EQUIV OF 5 MG OF PROSTAGLANDIN F2ALPHA PER MILLILITER; IT IS AVAIL IN 4- & 8-ML AMPULS FOR INTRA-AMNIOTIC ADMIN TO INDUCE ABORTION.
General Manufacturing Information · 5 Einträge

...20-CARBON UNSATURATED CARBOXYLIC ACIDS WITH CYCLOPENTANE RING. ...KINSHIP WITH ESSENTIAL FATTY ACIDS... MAIN CLASSES--E, F, A, B, C, & D-DISTINGUISHED BY CONSTITUENTS OF...RING. ...SUBDIVIDED...WITH NUMBER OF DOUBLE BONDS IN SIDE CHAINS. ...INDICATED BY SUBSCRIPT...REFLECTS FATTY ACID PRECURSOR. /PROSTAGLANDINS/

PROSTAGLANDINS OF E & FALPHA SERIES ARE SOMETIMES REFERRED TO AS "PRIMARY PROSTAGLANDINS". ...MOST ABUNDANT (ESP E2 & F2ALPHA)... /PROSTAGLANDINS/

IN VIVO MOST CELLS SEEM CAPABLE OF SYNTHESIZING PROSTAGLANDINS FROM ESSENTIAL FATTY ACID PRECURSORS. ...BELIEVED THAT ENDOGENOUS BIOSYNTHESIS, IN ABSENCE OF ADDED PRECURSOR ACID, DEPENDS ON PHOSPHOLIPASE-CATALYZED RELEASE OF PRECURSOR ACID FROM CELLULAR PHOSPHOLIPID STORES. /PROSTAGLANDINS/

SYNTH OF PRIMARY PROSTAGLANDINS...BY COMPLEX OF MICROSOMAL ENZYMES REFERRED TO AS "PROSTAGLANDIN SYNTHETASE." INITIAL EVENTS...RESULT IN OXYGENATION & CYCLIZATION OF UNESTERIFIED PRECURSOR ACID TO FORM CYCLIC PEROXIDE DERIV. ...ENDOPEROXIDE IS...REDUCED, YIELDING PGFALPHA COMPD. /PROSTAGLANDINS/

MOST PROLIFIC SOURCE OF NATURAL PROSTAGLANDINS IS MARINE ORGANISM CALLED GORGONIAN SEA WHIP, WHICH OCCURS...IN CORAL REEFS, ESP IN CARIBBEAN AREA. HARVESTING OF THESE HAS MADE PRODN...MUCH LESS EXPENSIVE. INTERMEDIATES & CHEM ANALOGS DERIVED FROM THIS NATURAL SOURCE...SYNTONS. /PROSTAGLANDINS/